Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case

Background. Mixed connective tissue disease (Sharp syndrome) is the rare chronic autoimmune pathology combining various features of systemic lupus erythematosus, systemic scleroderma, rheumatoid arthritis, dermatomyositis and high antibody titer to nuclear ribonucleoprotein. The mixed connective tis...

Full description

Bibliographic Details
Main Authors: Tamara P. Makarova, Khakim M. Vakhitov, Dina R. Sabirova, Dinara I. Sadykova, Liliya R. Khusnutdinova, Natalya N. Firsova, Anna A. Kucheryavaya
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2020-08-01
Series:Вопросы современной педиатрии
Subjects:
Online Access:https://vsp.spr-journal.ru/jour/article/view/2426
_version_ 1797700528099033088
author Tamara P. Makarova
Khakim M. Vakhitov
Dina R. Sabirova
Dinara I. Sadykova
Liliya R. Khusnutdinova
Natalya N. Firsova
Anna A. Kucheryavaya
author_facet Tamara P. Makarova
Khakim M. Vakhitov
Dina R. Sabirova
Dinara I. Sadykova
Liliya R. Khusnutdinova
Natalya N. Firsova
Anna A. Kucheryavaya
author_sort Tamara P. Makarova
collection DOAJ
description Background. Mixed connective tissue disease (Sharp syndrome) is the rare chronic autoimmune pathology combining various features of systemic lupus erythematosus, systemic scleroderma, rheumatoid arthritis, dermatomyositis and high antibody titer to nuclear ribonucleoprotein. The mixed connective tissue disease may evolve into other systemic diseases over time. Description of any cases of mixed connective tissue disease and its evolution in Russian patients has not been published previously.Clinical Case Description. The results of observations of the child with clinical and immunological signs of the mixed connective tissue disease followed by the progression of systemic scleroderma symptoms and development of Sjogren's syndrome in the short period of time are presented in the article. Improvement (such as pain attenuation, increase in volume of movements in affected joints, decrease of Raynaud syndrome manifestations duration) was observed on treatment (methotrexate 10 mg/week with subsequent addition of prednisolone 0.75 mg/kg/day).Conclusion. Timely diagnostics of clinical signs of the systemic diseases debut is crucial for correct patient routing and for achieving of disease improvement.
first_indexed 2024-03-12T04:23:12Z
format Article
id doaj.art-a8f6e174a7854cf7ac76a8ff7778d1a7
institution Directory Open Access Journal
issn 1682-5527
1682-5535
language English
last_indexed 2024-03-12T04:23:12Z
publishDate 2020-08-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj.art-a8f6e174a7854cf7ac76a8ff7778d1a72023-09-03T10:32:30Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352020-08-0119321421910.15690/vsp.v19i3.21171885Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical CaseTamara P. Makarova0Khakim M. Vakhitov1Dina R. Sabirova2Dinara I. Sadykova3Liliya R. Khusnutdinova4Natalya N. Firsova5Anna A. Kucheryavaya6Казанский государственный медицинский университетКазанский государственный медицинский университетКазанский государственный медицинский университетКазанский государственный медицинский университетКазанский государственный медицинский университетДетская республиканская клиническая больницаДетская республиканская клиническая больницаBackground. Mixed connective tissue disease (Sharp syndrome) is the rare chronic autoimmune pathology combining various features of systemic lupus erythematosus, systemic scleroderma, rheumatoid arthritis, dermatomyositis and high antibody titer to nuclear ribonucleoprotein. The mixed connective tissue disease may evolve into other systemic diseases over time. Description of any cases of mixed connective tissue disease and its evolution in Russian patients has not been published previously.Clinical Case Description. The results of observations of the child with clinical and immunological signs of the mixed connective tissue disease followed by the progression of systemic scleroderma symptoms and development of Sjogren's syndrome in the short period of time are presented in the article. Improvement (such as pain attenuation, increase in volume of movements in affected joints, decrease of Raynaud syndrome manifestations duration) was observed on treatment (methotrexate 10 mg/week with subsequent addition of prednisolone 0.75 mg/kg/day).Conclusion. Timely diagnostics of clinical signs of the systemic diseases debut is crucial for correct patient routing and for achieving of disease improvement.https://vsp.spr-journal.ru/jour/article/view/2426детисмешанное заболевание соединительной тканисиндром шарпаперекрестный синдромсиндром рейноартрит
spellingShingle Tamara P. Makarova
Khakim M. Vakhitov
Dina R. Sabirova
Dinara I. Sadykova
Liliya R. Khusnutdinova
Natalya N. Firsova
Anna A. Kucheryavaya
Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case
Вопросы современной педиатрии
дети
смешанное заболевание соединительной ткани
синдром шарпа
перекрестный синдром
синдром рейно
артрит
title Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case
title_full Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case
title_fullStr Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case
title_full_unstemmed Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case
title_short Evolution of Mixed Connective Tissue Disease in 7 Years Old Child: Clinical Case
title_sort evolution of mixed connective tissue disease in 7 years old child clinical case
topic дети
смешанное заболевание соединительной ткани
синдром шарпа
перекрестный синдром
синдром рейно
артрит
url https://vsp.spr-journal.ru/jour/article/view/2426
work_keys_str_mv AT tamarapmakarova evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase
AT khakimmvakhitov evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase
AT dinarsabirova evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase
AT dinaraisadykova evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase
AT liliyarkhusnutdinova evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase
AT natalyanfirsova evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase
AT annaakucheryavaya evolutionofmixedconnectivetissuediseasein7yearsoldchildclinicalcase